Shedding further light on the mystery of Alzheimer’s pathology, a new study shows that individuals with a neurodegenerative language disorder called primary progressive aphasia…
While Biogen’s experimental Alzheimer’s treatment aducanumab faced yet another snag recently in its convoluted path toward FDA approval, other drugs companies are catching up:…
This article was produced by Being Patient in partnership with Charter Research. More information on Alzheimer’s clinical trials can be found on the Charter…
Sponsored: This article was produced by Being Patient in partnership with Charter Research. More information on Alzheimer’s clinical trials can be found on the…
An Op-Ed by Benjamin Stecher Benjamin Stecher was diagnosed with Parkinson’s disease at the age of 29. He has since become actively involved in…
Alzheimer’s main hallmarks — beta-amyloid plaques and tau tangles — have long been the focus of the quest to come up with an Alzheimer’s…
Researchers found that the more severe people’s obstructive sleep apnea, the more likely they are to have a higher burden of beta-amyloid plaques in…